New York Assembly Bill A07817

New York 2025-2026 Regular Session

• Introduced: 4/11/25
• Refer: 4/11/25
• Refer: 1/7/26

Caption

Relates to excepting situations where a physician or other licensed health care provider is authorized to dispense certain medications and is practicing medicine in the oncology setting and is dispensing oncology drugs or drugs related to an approved course of treatment used to manage symptoms related to cancer or cancer therapies.

Impact

If enacted, A07817 would modify existing statutory language around medication dispensing in the oncology setting. This could streamline processes for healthcare providers, potentially reducing the administrative burden associated with obtaining prescriptions for oncology drugs. Moreover, it could enhance patient care by enabling immediate access to necessary medications during treatments, which is particularly crucial given the serious nature of cancer therapies.

Summary

Bill A07817 seeks to establish regulations around the dispensing of oncology drugs by licensed healthcare providers. Specifically, it provides exceptions wherein a physician or other authorized health care provider can dispense certain medications while practicing within the oncology field. This aims to facilitate better access to specialized medications for patients undergoing treatment for cancer, addressing needs in a critical area of healthcare where timely medication can significantly impact patient outcomes.

Contention

Despite its potential benefits, the bill could prompt discussions regarding the scope of authority granted to healthcare providers in dispensing medications. Proponents argue that allowing healthcare providers to dispense oncology drugs directly in their practice would create more efficient treatment pathways for patients. However, concerns may arise over the implications for patient safety, regulatory oversight, and the potential for confusion over medication management. Stakeholders might point to the need for robust guidelines and oversight mechanisms to ensure that patient safety remains the top priority.